Skip to content

Clinical trials

Phase 1/2 Neuroectodermal Tumors, Primitive, Peripheral trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroectodermal Tumors, Primitive, Peripheral Phase: Phase 1/2 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20071
20081
20101
20141
20151
20172
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)4
City of Hope Medical Center1
Dana-Farber Cancer Institute1
Duke University1
Eisai Inc.1
Fred Hutchinson Cancer Center1
St. Jude Children's Research Hospital1
University of Kentucky1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroectodermal Tumors, Primitive, Peripheral11
Sarcoma8
Rhabdomyosarcoma7
Neuroblastoma6
Osteosarcoma5
Central Nervous System Neoplasms4
Wilms Tumor4
Ovarian Neoplasms3
Rhabdoid Tumor3
Sarcoma, Ewing3

Trials

Showing 51 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.